Front Endocrinol (Lausanne) October 2023 PMID 37850091

The impact of obstructive sleep apnea on nonalcoholic fatty liver disease.

Haiying Tang, Furong Lv, Peng Zhang, Jia Liu, Jingwei Mao

Download social card

Mentions

Peak: 2 in Oct 2023

across 2 sources since Oct 2023

Extended reach

327,999

potential audience

Total likes

5,498

Video views

322,916

Mentions per month

Oct 2023 – Apr 2025

Where it's discussed

X / Twitter2 posts
YouTube2 videos

AI synopsis

What people are saying

The social discussions mostly consist of sharing informational summaries, such as highlighting the link between sleep apnea and fatty liver disease, with some posts using neutral terminology like 'new research' and 'characterized by'. The tone remains straightforward and factual, reflecting moderate interest and limited deep engagement.

AgreementNeither agree nor disagree

The posts briefly highlight the research without expressing strong approval or disagreement, mainly summarizing the study's focus.

InterestModerate interest

The discussions show mild curiosity, primarily through sharing headlines or summaries, indicating some interest but not deep engagement.

EngagementNeutral engagement

The language used is neutral and mainly informative, with little evidence of detailed discussion or analysis.

ImpactNeutral impact

The overall discussions seem to acknowledge the study's significance but lack evidence of wide influence or decisive opinions.

Abstract in brief

Obstructive sleep apnea (OSA) causes episodes where the airway collapses during sleep, leading to low oxygen levels, increased carbon dioxide, and waking up, which can damage multiple body systems including the heart, lungs, and metabolic processes.
OSA is closely linked with nonalcoholic fatty liver disease (NAFLD), and as both conditions become more common, they pose serious health risks.
Though more research is needed to fully understand how OSA influences NAFLD, current evidence suggests OSA worsens NAFLD and understanding this relationship could help in developing prevention and treatment strategies.]

Read the full abstract

All mentions

Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease Risk in Women

This study shows that women with polycystic ovary syndrome, especially those with higher androgen levels, are at increased risk of developing nonalcoholic fatty liver disease, highlighting the need for targeted liver…

دکتر بابک جمالیان · Apr 5, 2025 238,856 views

Polycystic Ovary Syndrome and Liver Disease Risk: A Longitudinal Study

This study shows that women with polycystic ovary syndrome, especially those with higher levels of androgens like testosterone and SHBG, have an increased risk of developing nonalcoholic fatty liver disease, based on a…

دکتر بابک جمالیان · Mar 13, 2025 84,060 views

Mohammad saleem baba.MBBS, MD, DM

@drsaleembaba · X

RT @FrontEndocrinol: New Research: The impact of obstructive sleep apnea on nonalcoholic fatty liver disease: Obstructive sleep apnea (OSA)…

Oct 2, 2023 · 1 share · 30 followers View post →

Frontiers - Endocrinology

@FrontEndocrinol · X

Oct 2, 2023 · 1 share · 5,050 followers View post →